Platinum Management’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
Other funds holding ARCT
BBA
BC
VM
DM
KCM
GPP
GTC
TI
PAI
Platinum Management's ARCT Position: Q1 2015 in Review
Platinum Management sold out of Arcturus Therapeutics (ARCT) in Q1 2015, closing a stake of 2,143 shares — an estimated $56K sold.
Platinum Management first reported a position in ARCT in Q3 2014 and held it in 2 quarters. The position peaked at $232K in Q3 2014. 28 funds tracked by Wall St. Rank hold ARCT as of Q1 2015.
- Platinum Management reported no remaining Arcturus Therapeutics position as of Q1 2015 after selling out during the quarter.
- Platinum Management sold 2,143 Arcturus Therapeutics shares in Q1 2015, an estimated $56K.
- Platinum Management first reported a position in Arcturus Therapeutics in Q3 2014 and held it in 2 quarters.
- Platinum Management's Arcturus Therapeutics position peaked at $232K in Q3 2014.
- 28 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2015.
Based on Platinum Management's 13F filing for Q1 2015, filed 15 May 2015.